Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Jean‐Cosme Dodart, Lauren Fedor et al.|Nature Medicine|2024Cited by 38
Modeled microgravity alters lipopolysaccharide and outer membrane vesicle production of the beneficial symbiont Vibrio fischeriMadeline M. Vroom, Jamie S. Foster, Yaneli Rodriguez-Ocasio et al.|npj Microgravity|2021Cited by 31
VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeysMadeline M. Vroom, Jean‐Cosme Dodart, Hanxin Lu et al.|Journal of Lipid Research|2024Cited by 23
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D. Boyd, Jean‐Cosme Dodart, Shixia Wang et al.|Communications Medicine|2025Cited by 2